title: A phase I study of intravenous plerixafor following cyclophosphamide mobilization in patients with multiple myeloma.
authors.affiliation: Department of Hematology & Hematopoietic Cell Transplantation.
authors.forename: Amrita Y
authors.initials: AY
authors.lastname: Krishnan
authors.forename: Shirong
authors.initials: S
authors.lastname: Wang
authors.forename: Joycelynne M
authors.initials: JM
authors.lastname: Palmer
authors.forename: Ni-Chun
authors.initials: NC
authors.lastname: Tsai
authors.forename: Sandra H
authors.initials: SH
authors.lastname: Thomas
authors.forename: Myo
authors.initials: M
authors.lastname: Htut
authors.forename: Len
authors.initials: L
authors.lastname: Farol
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Forman
mesh_terms: D061605:Administration, Intravenous; D000328:Adult; D000368:Aged; D001596:Benzylamines; D000080027:Cyclams; D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D019650:Hematopoietic Stem Cell Mobilization; D006571:Heterocyclic Compounds / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000628:therapy*; D019653:Myeloablative Agonists / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D001596:Benzylamines; D000080027:Cyclams; D006571:Heterocyclic Compounds; D019653:Myeloablative Agonists; D016179:Granulocyte Colony-Stimulating Factor; D003520:Cyclophosphamide; C088327:plerixafor